Skip to main content
BELLUSCURA PLC logo

BELLUSCURA PLC — Investor Relations & Filings

Ticker · BELL ISIN · GB00BD3B8Z11 LEI · 213800BRJQZE56XBPW94 IL Manufacturing
Open in API
Filings indexed 240 across all filing types
Latest filing 2021-10-18 Regulatory Filings
Country GB United Kingdom
Listing IL BELL

About BELLUSCURA PLC

https://belluscura.com/

Belluscura PLC is a medical device company specializing in the development and commercialization of advanced oxygen enrichment technologies. The company's primary focus is on manufacturing lightweight, portable oxygen concentrators (POCs) designed to improve the quality of life for individuals requiring supplemental oxygen therapy. Its product portfolio is headlined by the FDA-cleared X-PLOR® and the DISCOV-R™ models. These devices utilize proprietary, patented technologies such as ModulAir™ and an Airgonomical™ design to deliver high oxygen output in a compact form factor, offering an alternative to traditional, cumbersome oxygen tanks and promoting user mobility and independence.

Recent filings

Filing Released Lang Actions
New US Distribution Agreement
Regulatory Filings Classification · 99% confidence The document begins with an 'RNS Number' and is dated '18 October 2021'. It contains a headline 'New US Distribution Agreement' and discusses commercial updates, sales targets, and future shareholder updates regarding product deliveries. The footer explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This structure and source identification strongly indicate a general regulatory news service announcement, which aligns best with the 'Regulatory Filings' category (RNS), as it is not a specific financial report (like 10-K, IR, ER) or a specific corporate action announcement (like DIV, DIRS, CAP).
2021-10-18 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document is a notification filed via RNS (Regulatory News Service) on October 8, 2021. The content explicitly details a transaction involving the sale and subsequent purchase of shares by a Person Discharging Managerial Responsibilities (PDMR), specifically the Chief Financial Officer (Anthony Dyer). This perfectly matches the definition of a Director's Dealing report, which is categorized under the code DIRS. Although it is distributed via RNS, the specific nature of the content (insider trade disclosure) overrides the general RNS fallback.
2021-10-08 English
Half-year Report
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Half Year Report' and 'Unaudited Interim Results for the 6 months ended 30 June 2021'. It contains comprehensive financial statements, including a Consolidated Statement of Profit and Loss, Consolidated Balance Sheet, and Consolidated Statement of Changes in Equity. It is not a short announcement or a certification, but the full interim financial report itself, fitting the definition of an Interim / Quarterly Report (IR). H1 2021
2021-09-06 English
Notice of Results
Report Publication Announcement Classification · 99% confidence The document is very short (2575 characters) and explicitly states that the company 'announces that its unaudited interim results for the six month period ended 30 June 2021 will be released on Monday, 6 September 2021.' This is not the actual Interim Report (IR) itself, but an announcement about the future publication date of that report. According to Rule 2, when a document announces the publication of another report, it should be classified as a Report Publication Announcement (RPA). The presence of the RNS Number and the RNS footer further supports this being a regulatory announcement about a future filing.
2021-09-02 English
Belluscura supports rationale for wider oxygen use
Regulatory Filings Classification · 99% confidence The document begins with 'RNS Number : 0849K' and contains extensive boilerplate text describing 'RNS Reach announcements' as a 'non-regulatory press release distribution service' used for 'media only / non-regulatory news releases'. The content itself is an update regarding a statement from the American College of Chest Physicians (CHEST) concerning oxygen use coverage, which is corporate/industry news rather than a mandatory regulatory filing like a 10-K, ER, or IR. Since it is explicitly identified as a non-regulatory news release distributed via the RNS system, and it does not fit into any other specific category (like M&A, Dividend, or Management Change), the most appropriate classification is the general regulatory/news fallback category, RNS.
2021-08-31 English
Manufacturing and Distribution Agreement
Regulatory Filings Classification · 99% confidence The document begins with an 'RNS Number' and is dated July 27, 2021. It announces operational updates, specifically the commencement of manufacturing and signing a new distribution agreement for their product, X-PLO2R™. The text concludes with standard disclaimers referencing 'RNS, the news service of the London Stock Exchange' and the FCA. This format strongly indicates a general regulatory news service announcement rather than a detailed financial report (like 10-K or IR) or a specific corporate action filing (like DIV or CAP). Since it is a general regulatory announcement that doesn't fit the highly specific categories (like DIRS, MANG, or ER), the most appropriate fallback category is Regulatory Filings (RNS). The document length is relatively short (under 5,000 characters), supporting the idea that it is an announcement rather than the full report itself.
2021-07-27 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.